Table 2.
Frequency of dermatological manifestations in COVID-19.
| Author | Country | Frequency | n | Type of evaluation |
|---|---|---|---|---|
| Guan et al.3 | China | 0.2% | 1099 | Not in-person (database) |
| Recalcati et al.4 | Italy | 20.4% | 88 | In-person by dermatologist |
| Matar et al.5 | France | 1% | 756 | Self-examination by telephone interview |
| Rerknimitr et al.6 | Thailand | 15% | 183 | Self-examination by telephone interview |
| Solak et al.7 | Turkey | 18.3% | 382 | Self-examination by telephone interview |
| Gaspari et al.8 | Italy | 1.4% | NA | In-person by dermatologist |
| Tammaro et al.9 | Italy | 1.5% | 130 | In-person by dermatologist |
| Tamai et al.10 | Japan | 4.3% | 69 | In-person by dermatologist |
| De Giorgi et al.31 | Italy/China | 7.8% | 678 | In-person (does not specify evaluator) |
| Rehktman et al.32 | USA | 11.8% | 296 | In-person by medical students |
| Méndez-Maestro et al.30 | Spain | 18.7% | 75 | In-person by dermatologist |
| Nuno-Gonzales et al.34 | Spain | 45.65% | 666 | In-person by dermatologist |
| Jamshindi et al.36 | NAa | 5.95% | 1847 | NAa |
NA, Not Available data.
Meta-analysis study.